A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer
Triple-negative breast cancer
DOI:
10.1021/acs.nanolett.7b00132
Publication Date:
2017-04-18T19:17:32Z
AUTHORS (13)
ABSTRACT
Ruthenium coordination complexes have the potential to serve as novel theranostic agents for cancer. However, a major limitation in their clinical implementation is effective tumor accumulation. In this study, we developed liposome-based nanodelivery system [Ru(phen)
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (121)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....